Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma

Clinical and Experimental Metastasis

Volumn 30, Issue 5, 2013, Pages 651-658

  Chen, Hongyuan ^a   Miao, Ruizheng ^b   Fan, Junwei ^a   Han, Zhongbo ^c   Wu, Junyi ^a   Qiu, Guoqiang ^a   Tang, Huamei ^a   Peng, Zhihai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c Central Hospital of Zibo   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Metastasis; miR 126

Indexed keywords

MICRORNA 126;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; METASTASIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; REAL-TIME POLYMERASE CHAIN REACTION; RECURRENCE;

EID: 84878584887     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9569-6     Document Type: Article

References (32)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557-2576
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
3. Thomas (2010) Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting (vol 28, pg 3994, 2010). J Clin Oncol 28(36):5350-5550
4. Hanahan D (2000) The hallmarks of cancer. Cell 100(1):57-70
5. White NMA, Fatoohi E, Metias M, Jung K, Stephan C, Yousef GM (2010) Metastamirs: a stepping stone towards improved cancer management. Nat Rev Clin Oncol 8(2):75-84
6. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215-233
7. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
8. Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350-355
9. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136(4):586-591
10. Iorio MV, Croce CM (2009) MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27(34):5848-5856
11. Valastyan S, Reinhardt F, Benaich N et al (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6):1032-1046
12. Korpal M, Ell BJ, Buffa FM et al (2011) Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17(9):0-8
13. Schlitt HJ, Neipp M, Weimann A et al (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17(1):324-331
14. Han ZB, Zhong L, Teng MJ et al (2012) Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol 6(4):445-457
15. Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33(6):1394-1403
16. Anglicheau D, Sharma VK, Ding R et al (2009) MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci 106(13):5330-5335
17. Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127(4):679-695
18. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6(4):259-269
19. Garzon R, Calin GA, Croce CM (2009) MicroRNAs in cancer. Annu Rev Med 60:167-179
20. Huang S, He X (2010) The role of microRNAs in liver cancer progression. Br J Cancer 104(2):235-240
21. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449(7163):682-688
22. Bhaumik D, Scott G, Schokrpur S, Patil C, Campisi J, Benz C (2008) Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27(42):5643-5647
23. Wong CCL, Wong CM, Tung EKK et al (2011) The MicroRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-Kinase 2. Gastroenterology 140(1):322-331
24. Yao J, Liang L, Huang S et al (2010) MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 51(3):846-856
25. Budhu A, Jia HL, Forgues M et al (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47(3):897-907
26. Wong QWL, Lung RWM, Law PTY et al (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of stathmin 1. Gastroenterology 135(1):257-269
27. Huang XH, Wang Q, Chen JS et al (2009) Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 39(8):786-794
28. Tavazoie SF, Alarcon C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175):147-152
29. Liu B, Peng XC, Zheng XL, Wang J, Qin YW (2009) MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66(2):169-175
30. Feng R, Chen X, Yu Y et al (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298(1):50-63
31. Hamada S, Satoh K, Fujibuchi W et al (2011) miR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Mol Cancer Res. doi: 10.1158/1541-7786.mcr-11-0272
32. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693-699